EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieKlinische Studie (Phase II)Open Access · CC BY 4.0

[177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial

David L Chan, Katrin Marie Sjoquist, David Turner Ransom, David Wyld, Kate Wilson, Val Gebski, James Murray, Andrew Ddembe Kiberu, Matthew E Burge, William Macdonald, Paul Roach, David A Pattison und 10 weitere

European Journal of Cancer · 2026-06 · 241 · 116781

DOI: 10.1016/j.ejca.2026.116781 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026-06. Verfasst von David L Chan und 21 weiteren Autor:innen. Beteiligte Einrichtung: Royal North Shore Hospital, St Leonards, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Australia. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms, Temozolomide, Octreotide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australasian Gastro-Intestinal Trials Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsPancreatic NeoplasmsTemozolomideOctreotideOrganometallic CompoundsAntineoplastic Combined Chemotherapy ProtocolsIntestinal NeoplasmsHumansFemaleMiddle AgedCapecitabineMaleAgedAdultProgression-Free SurvivalIntestine, Small

Stichwörter der Autor:innen

CAPTEMClinical trialNeuroendocrine tumoursPRCRTPRRTRandomized

Substanzen

TemozolomideOctreotideOrganometallic Compoundslutetium Lu 177 dotatateCapecitabine

Autor:innen und Institutionen

  • Royal North Shore Hospital, St Leonards, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Australia.
  • St George Hospital, Kogarah, NSW, Australia; NHMRC Clinical Trials Centre, Camperdown, NSW, Australia.
  • Fiona Stanley Hospital, Murdoch, WA, Australia.
  • Royal Brisbane and Women's Hospital, Herston, QLD, Australia; Faculty of Medicine, University of Queensland, QLD, Australia.
  • NHMRC Clinical Trials Centre, Camperdown, NSW, Australia.
  • St George Hospital, Kogarah, NSW, Australia.

Förderung

  • Australasian Gastro-Intestinal Trials Group

Zitieren

APA

Chan, D. L., Sjoquist, K. M., Ransom, D. T., Wyld, D., Wilson, K., Gebski, V., Murray, J., Kiberu, A. D., Burge, M. E., Macdonald, W., Roach, P., Pattison, D. A., Butler, P., Price, T. J., Michael, M., Lawrence, B. J., Bailey, D. L., Leyden, J., Leyden, S., …, & Pavlakis, N. (2026). [177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial. European Journal of Cancer, 241, 116781. https://doi.org/10.1016/j.ejca.2026.116781

Vancouver

Chan DL, Sjoquist KM, Ransom DT, Wyld D, Wilson K, Gebski V, et al. [177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial. European Journal of Cancer. 2026;241:116781. doi:10.1016/j.ejca.2026.116781

BibTeX
@article{Chan2026,
  author = {Chan, David L and Sjoquist, Katrin Marie and Ransom, David Turner and Wyld, David and Wilson, Kate and Gebski, Val and Murray, James and Kiberu, Andrew Ddembe and Burge, Matthew E and Macdonald, William and Roach, Paul and Pattison, David A and Butler, Patrick and Price, Timothy Jay and Michael, Michael and Lawrence, Benjamin James and Bailey, Dale L and Leyden, John and Leyden, Simone and Zalcberg, John Raymond and Turner, J Harvey and Pavlakis, Nick},
  title = {[177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {241},
  pages = {116781},
  doi = {10.1016/j.ejca.2026.116781}
}
Kostenlos starten →